Jan Skvarka

Business address
C/O Trillium Therapeutics Inc., 2488 Dunwin Drive, Mississauga, Ontario, Canada, L5L 1J9
Top holdings (ownership)
ZNTL
⭐ Add to watchlist ⭐
Get insider transactions for this reporting owner
Jan Skvarka has filed 17 SEC EDGAR filings since 04 Jan 2021

Latest Filings

Form type Document Filing Description Filing date Reporting date File number(s)
4 Open Document Open Filing FORM 4 18 Jun 2025 17 Jun 2025 001-39263
4 Open Document Open Filing 4 16 Jun 2025 13 Jun 2025 001-40522
4 Open Document Open Filing FORM 4 04 Feb 2025 31 Jan 2025 001-39263
4 Open Document Open Filing FORM 4 21 Jun 2024 21 Jun 2024 001-39263
4 Open Document Open Filing 4 13 Jun 2024 12 Jun 2024 001-40522
4 Open Document Open Filing FORM 4 13 Sep 2023 11 Sep 2023 001-39263
144 Open Document Open Filing 11 Sep 2023
4 Open Document Open Filing FORM 4 16 Jun 2023 16 Jun 2023 001-39263
4 Open Document Open Filing FORM 4 SUBMISSION 15 Jun 2023 14 Jun 2023 001-40522
4 Open Document Open Filing FORM 4 SUBMISSION 31 Mar 2023 30 Mar 2023 001-40522
3 Open Document Open Filing FORM 3 SUBMISSION 24 Mar 2023 23 Mar 2023 001-40522
4 Open Document Open Filing FORM 4 12 Sep 2022 09 Sep 2022 001-39263
3 Open Document Open Filing FORM 3 12 Sep 2022 09 Sep 2022 001-39263
4 Open Document Open Filing OWNERSHIP DOCUMENT 19 Nov 2021 17 Nov 2021 001-36596
4 Open Document Open Filing STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 13 May 2021 11 May 2021 001-36596
4 Open Document Open Filing STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 15 Jan 2021 13 Jan 2021 001-36596
3 Open Document Open Filing INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES 04 Jan 2021 01 Jan 2021 001-36596